Literature DB >> 26276390

The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.

Joel Jules1, Shunqing Wang2, Zhenqi Shi1, Jianzhong Liu1, Shi Wei1, Xu Feng3.   

Abstract

Receptor activator of NF-κB (RANK) activation by RANK ligand (RANKL) mediates osteoclastogenesis by recruiting TNF receptor-associated factors (TRAFs) via three cytoplasmic motifs (motif 1, PFQEP(369-373); motif 2, PVQEET(559-564); and motif 3, PVQEQG(604-609)) to activate the NF-κB and MAPK signaling pathways. RANK also has a TRAF-independent motif (IVVY(535-538)), which is dispensable for the activation of TRAF-induced signaling pathways but essential for osteoclast lineage commitment by inducing the expression of nuclear factor of activated T-cells c1 (NFATc1) to regulate osteoclast gene expression. Notably, TNF/IL-1-mediated osteoclastogenesis requires RANK ligand assistance, and the IVVY motif is also critical for TNF/IL-1-mediated osteoclastogenesis by rendering osteoclast genes responsive to these two cytokines. Here we show that the two types of RANK cytoplasmic motifs have to be on the same RANK molecule to mediate osteoclastogenesis, suggesting a functional cooperation between them. Subsequent osteoclastogenesis assays with TNF or IL-1 revealed that, although all three TRAF motifs play roles in TNF/IL-1-mediated osteoclastogenesis, motifs 2 and 3 are more potent than motif 1. Accordingly, inactivation of motifs 2 and 3 blocksTNF/IL-1-mediated osteoclastogenesis. Mechanistically, double mutation of motifs 2 and 3, similar to inactivation of the IVVY motif, abrogates the expression of nuclear factor of activated T-cells c1 and osteoclast genes in assays reflecting RANK-initiated and TNF/IL-1-mediated osteoclastogenesis. In contrast, double inactivation of motifs 2 and 3 did not affect the ability of RANK to activate the NF-κB and MAPK signaling pathways. Collectively, these results indicate that the RANK IVVY motif cooperates with the TRAF-binding motifs to promote osteoclastogenesis, which provides novel insights into the molecular mechanism of RANK signaling in osteoclastogenesis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  IL-1; IVVY motif; RANK; RANKL; TNF; TNF receptor-associated factor (TRAF); cell signaling; osteoclast

Mesh:

Substances:

Year:  2015        PMID: 26276390      PMCID: PMC4583028          DOI: 10.1074/jbc.M115.667535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.

Authors:  J i Inoue; T Ishida; N Tsukamoto; N Kobayashi; A Naito; S Azuma; T Yamamoto
Journal:  Exp Cell Res       Date:  2000-01-10       Impact factor: 3.905

Review 2.  The molecular architecture of the TNF superfamily.

Authors:  Jean-Luc Bodmer; Pascal Schneider; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

Review 3.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 4.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

5.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors:  J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.

Authors:  X Feng; D V Novack; R Faccio; D S Ory; K Aya; M I Boyer; K P McHugh; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 7.  The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.

Authors:  D T Graves; D Cochran
Journal:  J Periodontol       Date:  2003-03       Impact factor: 6.993

8.  Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis.

Authors:  Han Kyoung Choi; Hye Ri Kang; Eutteum Jung; Tae Eon Kim; Jing Jing Lin; Soo Young Lee
Journal:  Cell Res       Date:  2013-03-12       Impact factor: 25.617

9.  RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

Authors:  Ping Li; Edward M Schwarz; Regis J O'Keefe; Lin Ma; Brendan F Boyce; Lianping Xing
Journal:  J Bone Miner Res       Date:  2004-02       Impact factor: 6.741

10.  A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function.

Authors:  Allison P Armstrong; Mark E Tometsko; Moira Glaccum; Claire L Sutherland; David Cosman; William C Dougall
Journal:  J Biol Chem       Date:  2002-08-15       Impact factor: 5.157

View more
  9 in total

1.  Specific RANK Cytoplasmic Motifs Drive Osteoclastogenesis.

Authors:  Yuyu Li; Zhenqi Shi; Joel Jules; Shenyuan Chen; Robert A Kesterson; Dongfeng Zhao; Ping Zhang; Xu Feng
Journal:  J Bone Miner Res       Date:  2019-08-02       Impact factor: 6.741

2.  C/EBPα transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos.

Authors:  Joel Jules; Wei Chen; Xu Feng; Yi-Ping Li
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

3.  C/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis.

Authors:  Joel Jules; Yi-Ping Li; Wei Chen
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

Review 4.  Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis.

Authors:  Junjie Lu; Desheng Hu; Chen Ma; Bo Shuai
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

5.  CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity.

Authors:  Joel Jules; Wei Chen; Xu Feng; Yi-Ping Li
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

6.  Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.

Authors:  Jiyeon Yu; Hyeongseok Yun; Bongjin Shin; Yongjin Kim; Eui-Soon Park; Seunga Choi; Jungeun Yu; Dulshara Sachini Amarasekara; Sumi Kim; Jun-Ichiro Inoue; Matthew C Walsh; Yongwon Choi; Masamichi Takami; Jaerang Rho
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

7.  l-tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK-TRAF6 interactions and inhibiting NF-κB and MAPK pathways.

Authors:  Xin Zhi; Lipeng Wang; Huiwen Chen; Chao Fang; Jin Cui; Yan Hu; Liehu Cao; Weizong Weng; Qirong Zhou; Longjuan Qin; Hongyuan Song; Yajun Wang; Yao Wang; Hao Jiang; Xiaoqun Li; Sicheng Wang; Xiao Chen; Jiacan Su
Journal:  J Cell Mol Med       Date:  2019-11-14       Impact factor: 5.310

8.  Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways.

Authors:  Wei Shang; Ling-Jie Zhao; Xiao-Lei Dong; Zhi-Ming Zhao; Jing Li; Bei-Bei Zhang; Hui Cai
Journal:  Mol Med Rep       Date:  2016-08-25       Impact factor: 2.952

9.  In Vivo siRNA Delivery Using JC Virus-like Particles Decreases the Expression of RANKL in Rats.

Authors:  Daniel B Hoffmann; Kai O Böker; Stefan Schneider; Ellen Eckermann-Felkl; Angelina Schuder; Marina Komrakova; Stephan Sehmisch; Jens Gruber
Journal:  Mol Ther Nucleic Acids       Date:  2016-03-22       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.